Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Similar articles for PubMed (Select 24711443)

1.

Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens.

Brandler TC, Aziz MS, Rosen LM, Bhuiya TA, Yaskiv O.

Cancer Cytopathol. 2014 Jun;122(6):468-73. doi: 10.1002/cncy.21424. Epub 2014 Apr 7.

PMID:
24711443
2.

Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems.

Eriksson P, Aine M, Veerla S, Liedberg F, Sjödahl G, Höglund M.

BMC Med Genomics. 2015 May 26;8:25. doi: 10.1186/s12920-015-0101-5.

3.
4.
5.

Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites.

Cheng KA, Kurtis B, Babayeva S, Zhuge J, Tantchou I, Cai D, Lafaro RJ, Fallon JT, Zhong M.

Ann Diagn Pathol. 2015 Jun;19(3):146-8. doi: 10.1016/j.anndiagpath.2015.03.005. Epub 2015 Mar 17.

PMID:
25862495
6.

Differential Expression Patterns of GATA3 in Uterine Mesonephric and Nonmesonephric Lesions.

Roma AA, Goyal A, Yang B.

Int J Gynecol Pathol. 2015 Apr 1. [Epub ahead of print]

PMID:
25851711
7.

Immunostaining of ∆Np63 (using the p40 antibody) is equal to that of p63 and CK5/6 in high-grade ductal carcinoma in situ of the breast.

Sailer V, Lüders C, Kuhn W, Pelzer V, Kristiansen G.

Virchows Arch. 2015 Apr 8. [Epub ahead of print]

PMID:
25850754
8.

Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung.

Hattori Y, Yoshida A, Yoshida M, Takahashi M, Tsuta K.

Pathol Int. 2015 Jun;65(6):286-92. doi: 10.1111/pin.12278. Epub 2015 Mar 2.

PMID:
25727644
9.

Cytomorphology of sebaceous carcinoma with analysis of p40 antibody expression.

Jain D, Mathur SR, Sharma MC, Iyer VK.

Diagn Cytopathol. 2015 Jun;43(6):456-61. doi: 10.1002/dc.23250. Epub 2015 Jan 22.

PMID:
25611456
10.

Uroplakin II (UPII), GATA3, and p40 are Highly Sensitive Markers for the Differential Diagnosis of Invasive Urothelial Carcinoma.

Hoang LL, Tacha D, Bremer RE, Haas TS, Cheng L.

Appl Immunohistochem Mol Morphol. 2015 Jan 21. [Epub ahead of print]

PMID:
25611245
11.
12.

Atypical/malignant urothelial cells in routine urinary sediment: worth knowing and reporting.

Fogazzi GB, Pallotti F, Garigali G.

Clin Chim Acta. 2015 Jan 15;439:107-11. doi: 10.1016/j.cca.2014.10.021. Epub 2014 Oct 17.

PMID:
25451946
13.

p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma.

Alomari AK, Glusac EJ, McNiff JM.

J Cutan Pathol. 2014 Nov;41(11):839-45. doi: 10.1111/cup.12388. Epub 2014 Oct 21.

PMID:
25263848
14.

Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma.

Ha Lan TT, Chen SJ, Arps DP, Fullen DR, Patel RM, Siddiqui J, Carskadon S, Palanisamy N, Harms PW.

J Cutan Pathol. 2014 Nov;41(11):831-8. doi: 10.1111/cup.12387. Epub 2014 Nov 3.

PMID:
25263756
15.

Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens.

Braxton DR, Cohen C, Siddiqui MT.

Diagn Cytopathol. 2015 Apr;43(4):271-7. doi: 10.1002/dc.23206. Epub 2014 Aug 4.

PMID:
25088841
16.

p40 is more specific than p63 for the distinction of atypical fibroxanthoma from other cutaneous spindle cell malignancies.

Henderson SA, Torres-Cabala CA, Curry JL, Bassett RL, Ivan D, Prieto VG, Tetzlaff MT.

Am J Surg Pathol. 2014 Aug;38(8):1102-10. doi: 10.1097/PAS.0000000000000245.

PMID:
25029117
17.

The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma.

Lin X, Zhu B, Villa C, Zhong M, Kundu S, Rohan SM, Yang XJ.

Hum Pathol. 2014 Sep;45(9):1824-9. doi: 10.1016/j.humpath.2014.04.015. Epub 2014 May 8.

PMID:
24993315
18.

Expression of ProEx C in primary and metastatic urothelial carcinoma.

Liu L, Cohen C, Siddiqui MT.

Diagn Cytopathol. 2015 Mar;43(3):181-7. doi: 10.1002/dc.23193. Epub 2014 Jun 28.

PMID:
24975746
19.

Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas.

Clark BZ, Beriwal S, Dabbs DJ, Bhargava R.

Am J Clin Pathol. 2014 Jul;142(1):64-71. doi: 10.1309/AJCP8H2VBDSCIOBF.

20.

GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin.

Bezerra SM, Lotan TL, Faraj SF, Karram S, Sharma R, Schoenberg M, Bivalacqua TJ, Netto GJ.

Hum Pathol. 2014 Aug;45(8):1682-7. doi: 10.1016/j.humpath.2014.04.011. Epub 2014 Apr 24.

PMID:
24925221
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk